tiprankstipranks
Advertisement
Advertisement

Starcoin Secures Exclusive Rights to Tokenize Brazilian Gold Mine Assets

Story Highlights
  • Starcoin Group clinched exclusive global rights to design, issue, and trade digital tokens backed by two Brazilian gold mines.
  • The agreement grants Starcoin revenue shares from token issuance and gold sales, bolstering its position in real-world asset tokenization.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Starcoin Secures Exclusive Rights to Tokenize Brazilian Gold Mine Assets

Claim 55% Off TipRanks

Innovative Pharmaceutical Biotech ( (HK:0399) ) has shared an update.

Starcoin Group Limited has entered into an exclusive management agreement via its subsidiary Starcoin Hong Kong Limited with Brazil-based Nhandu Parkent Mineracao and U.S.-incorporated Goldcoin Global Asset Management to tokenize real-world assets from two gold mining areas in Mato Grosso, Brazil. The deal grants Starcoin global exclusive rights to design, issue, list, and trade digital tokens backed by the mines’ gold reserves, mining rights revenue, future cash flows, and related assets using Web3.0 technology.

Under the agreement, Nhandu Parkent will refrain from issuing any digital assets tied to the mines without Starcoin’s consent, while Starcoin will receive 5% of total token issuance and 5% of gold sales revenue from the targeted areas. The move positions Starcoin to capture value from sizable, high-grade gold reserves in one of South America’s largest gold mining centers, strengthening its presence in the emerging real-world asset tokenization niche and potentially enhancing revenue diversification for the group and related stakeholders.

The most recent analyst rating on (HK:0399) stock is a Sell with a HK$0.15 price target. To see the full list of analyst forecasts on Innovative Pharmaceutical Biotech stock, see the HK:0399 Stock Forecast page.

More about Innovative Pharmaceutical Biotech

Starcoin Group Limited, formerly Innovative Pharmaceutical Biotech Limited, is a Cayman Islands–incorporated company continued in Bermuda that has shifted its focus toward digital assets and Web3.0 solutions. Through its wholly owned subsidiary Starcoin Hong Kong Limited, the group is expanding into real-world asset tokenization, targeting resource-based projects such as gold mines in international markets.

Average Trading Volume: 41,524,017

Technical Sentiment Signal: Sell

Current Market Cap: HK$413.6M

For a thorough assessment of 0399 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1